Table 3. Characteristics of female SSNHL and control subjects stratified by 50 years of age.
Female SSNHL patients ≥ 50 y/o had significant higher average IMT value and more percentage of high average IMT (≥ 0.65 mm) than those in the female control group ≥50 y/o. P values < 0.05 are considered statistically significant and are bolded.
SSNHL | Control | P Value | |
---|---|---|---|
Age, mean (SD), year | |||
≥50 y/o | 62.2 (7.8) | 56.9 (4.9) | 0.095 |
<50 y/o | 38.4 (11.3) | 37.5 (10.6) | 0.875 |
DM, n (%) | |||
≥50 y/o | |||
Yes | 4 (25%) | 0 (0%) | 0.262 |
No | 12 (75%) | 8 (100%) | |
<50 y/o | |||
Yes | 0 (0%) | 2 (25%) | 0.467 |
No | 8 (100%) | 6 (75%) | |
HTN, n (%) | |||
≥50 y/o | |||
Yes | 6 (37.5%) | 1 (12.5%) | 0.352 |
No | 10 (62.5%) | 7 (87.5%) | |
<50 y/o | |||
Yes | 0 (0%) | 2 (25%) | 0.467 |
No | 8 (100%) | 6 (75%) | |
Total cholesterol, mean (SD), mg/dl | |||
≥50 y/o | 194.3 (37.9) | 182.8 (42.6) | 0.574 |
<50 y/o | 202.8 (29.3) | 205.8 (34.9) | 0.873 |
LDL cholesterol, mean (SD), mg/dl | |||
≥50 y/o | 116.1 (37.9) | 96.2 (30.7) | 0.304 |
<50 y/o | 119.4 (36.3) | 99.8 (28.7) | 0.331 |
HDL cholesterol, median (IQR), mg/dl | |||
≥50 y/o | 57 (53–68) | 68 (49.5–82) | 0.382 |
<50 y/o | 58.5 (54.5–72) | 70 (47–118.5) | 0.769 |
Average IMT, median (IQR), mm | |||
≥50 y/o | 0.72 (0.62–1.08) | 0.63 (0.58–0.64) | 0.016 |
<50 y/o | 0.54 (0.47–0.59) | 0.55 (0.48–0.56) | 0.752 |
Average IMT, n (%) | |||
≥50 y/o | |||
High (≥0.65 mm) | 12 (75%) | 2 (25%) | 0.032 |
Low (<0.65 mm) | 4 (25%) | 6 (75%) | |
<50 y/o | |||
High (≥0.65 mm) | 7 (87.5%) | 8 (100%) | 1.000 |
Low (<0.65 mm) | 1 (12.5%) | 0 (0%) |
Note:
SSNHL, sudden sensorineural hearing loss; DM, diabetes mellitus; HTN, hypertension; LDL, low-density lipoprotein; HDL, high-density lipoprotein; IMT, intima-media thickness; y/o, years old.